Company Filing History:
Years Active: 2005-2008
Title: Inventor Elisabeth von der Mark: Pioneering Developments in Medical Treatments
Elisabeth von der Mark, based in Bad Bellingen, Germany, is a prominent inventor with a keen focus on medicinal chemistry. With two notable patents to her name, she has made significant contributions to the field, particularly concerning the development of innovative treatments for various health conditions.
Latest Patents
The latest patented inventions by Elisabeth von der Mark include aminocyclohexanol derivatives that serve as 2,3-oxidosqualene-lanosterol cyclase inhibitors. These compounds are designed to offer both treatment and prophylaxis for a range of diseases associated with dysfunctions in the 2,3-oxidosqualene-lanosterol cyclase pathway. The conditions targeted by her inventions include hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors, and hyperproliferative disorders. Additionally, they aim to address impaired glucose tolerance and diabetes, showcasing the versatility and potential impact of her work.
Career Highlights
Elisabeth von der Mark works at Hoffmann-La Roche Inc., a noted global healthcare company specializing in pharmaceuticals and diagnostics. Her position within such a distinguished organization emphasizes her expertise and the valuable nature of her contributions to medical science.
Collaborations
Throughout her career, Elisabeth has collaborated with esteemed colleagues, including Jean Ackermann and Johannes Aebi. These partnerships foster an environment of innovation and idea-sharing, further enhancing the development of her groundbreaking inventions.
Conclusion
In summary, Elisabeth von der Mark exemplifies the spirit of innovation in the medical field with her patents that hold promise for treating various serious health conditions. Her work not only reflects her dedication to improving patient outcomes but also highlights the importance of collaboration in advancing scientific progress.